Arrowhead Pharmaceuticals Inc (ARWR)
SG&A Expense Growth
14.25%
Quarterly · Period ending:
ARWR SG&A Expense Growth
Latest reported14.25%period ending
Latest reported14.25%period ending
ARWR Quarterly SG&A Growth (QoQ) (0.00% → 14.25%)
Latest values, visible window
High-resolution chart · PNG
ARWR sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 14.2542% | |
| -9.3877% | |
| 22.4365% | |
| 22.1127% | |
| 9.1418% | |
| 5.6551% | |
| 2.385% | |
| 11.1609% | |
| -5.8716% | |
| 6.2562% | |
| -4.0303% | |
| 3.4236% | |
| 2.415% | |
| 10.8541% | |
| -34.9165% | |
| -3.4028% | |
| -3.3222% | |
| 37.6993% | |
| -35.7693% | |
| 114.4089% | |
| 10.2965% | |
| 87.2109% | |
| -39.3848% | |
| 34.6646% | |
| -34.4917% | |
| 49.9484% | |
| 5.0669% | |
| 113.6769% | |
| -9.9153% | |
| -13.0691% | |
| -4.5216% | |
| 40.0308% | |
| 24.8953% | |
| -16.4279% | |
| -53.8675% | |
| 143.0934% | |
| 6.5962% | |
| -57.0137% | |
| -34.8104% | |
| 43.5809% | |
| -12.8215% | |
| 27.0489% | |
| -32.0112% | |
| 53.9065% | |
| 5.9468% | |
| 2.6432% | |
| -20.8443% | |
| 50.7883% | |
| 7.6465% | |
| 60.4914% | |
| 18.2159% | |
| 2.0538% | |
| 1.9125% | |
| -2.8042% | |
| 0.4155% | |
| -43.7311% | |
| 67.0705% | |
| 9.7866% | |
| 194.0293% | |
| -27.8282% | |
| -16.5346% | |
| 22.4153% | |
| -40.343% | |
| 81.7583% | |
| 8.6407% | |
| -43.0359% | |
| -25.5348% | |
| 12.5675% | |
| -38.8092% | |
| -28.213% | |
| -20.3281% | |
| 2.045% | |
| 16.1318% | |
| 8.1183% | |
| -2.5016% | |
| 6.4021% | |
| 29.5473% | |
| 33.5418% | |
| -8.387% | |
| -13.4334% | |
| 29.6804% | |
| 63.3186% | |
| 103.8038% | |
| -48.2651% | |
| 25.0808% | |
| 13.636% | |
| -11.4904% | |
| 223.8304% | |
| 2.8684% | |
| 376.6888% | |
| 601.3638% | |
| -23.7924% | |
| -49.5465% | |
| -10.2392% | |
| -24.3641% | |
| -9.0939% | |
| 113.9243% | |
| -15.0534% | |
| 9.8083% | |
| 31.9153% |